Aquinox Pharmaceuticals Phase 2 KINSHIP Trial With AQX-1125 in Patients With Atopic Dermatitis Fails to Demonstrate Efficacy

By: via Benzinga
Aquinox Pharmaceuticals,Inc. ("Aquinox") (Nasdaq: AQXP) announced Monday, its Phase 2 KINSHIP clinical trial failed to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.